Reduced Toll-Like Receptor 3 Expression in Chronic Hepatitis B Patients and Its Restoration by Interferon Therapy
Antiviral Therapy2013Vol. 18(7), pp. 877–884
Citations Over TimeTop 10% of 2013 papers
Yi‐Wen Huang, Shih‐Chang Lin, Shu‐Chen Wei, Jui-Ting Hu, Han-Yu Chang, Shih-Hung Huang, Ding‐Shinn Chen, Pei‐Jer Chen, Ping‐Ning Hsu, Sien-Sing Yang, Jia‐Horng Kao
Abstract
CHB patients have reduced TLR3 expression on PBMCs, independent of age, gender and ALT, and on liver cells. Patients with pegylated-interferon-induced SVR have a more significant restoration of TLR3 expression than those under entecavir.
Related Papers
- → Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment(2015)73 cited
- → Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains(2010)8 cited
- Clinical effect of entecavir in patients with decompensated hepatitis B cirrhosis(2010)
- Efficacy of Entecavir for patients of chronic severe-degree hepatitis B with HBeAg-positive(2010)
- → Efficacy of Entecavir for patients of chronic severe-degree hepatitis B with HBeAg-posi-tive(2010)